DK258687D0 - Intranaslat praeparat - Google Patents

Intranaslat praeparat

Info

Publication number: DK258687D0
Authority: DK; Denmark
Prior art keywords: amount; effective amount; intranaslat; preparation; inflammatory steroid
Prior art date: 1986-05-22

Application number

DK258687A

Other languages

English (en)

Other versions

DK258687A (da

DK175238B1 (da

Inventor

Eric Joel Benjamin

Shabbir Tyabji Anik

Ya-Yun Tracy Lin

Original Assignee

Syntex Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-05-22

Filing date

1987-05-21

Publication date

1987-05-21

1987-05-21 Application filed by Syntex Inc filed Critical Syntex Inc

1987-05-21 Publication of DK258687D0 publication Critical patent/DK258687D0/da

1987-11-23 Publication of DK258687A publication Critical patent/DK258687A/da

2004-07-19 Application granted granted Critical

2004-07-19 Publication of DK175238B1 publication Critical patent/DK175238B1/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Otolaryngology (AREA)
General Chemical & Material Sciences (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK198702586A 1986-05-22 1987-05-21 Vandige steroidformuleringer, fremgangsmåde til fremstilling deraf samt anvendelse af sådanne steroidformuleringer til fremstilling af et medikament til behandling af den nasale mucosa DK175238B1 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US86617186		1986-05-22
US06/866,171 US4782047A (en)	1986-05-22	1986-05-22	Aqueous steroid formulations for nasal administration

Publications (3)

Publication Number	Publication Date
DK258687D0 true DK258687D0 (da)	1987-05-21
DK258687A DK258687A (da)	1987-11-23
DK175238B1 DK175238B1 (da)	2004-07-19

Family

ID=25347059

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK198702586A DK175238B1 (da)	1986-05-22	1987-05-21	Vandige steroidformuleringer, fremgangsmåde til fremstilling deraf samt anvendelse af sådanne steroidformuleringer til fremstilling af et medikament til behandling af den nasale mucosa

Country Status (19)

Country	Link
US (1)	US4782047A (da)
EP (1)	EP0246652B1 (da)
JP (1)	JP2521291B2 (da)
KR (1)	KR950008308B1 (da)
AT (1)	ATE65183T1 (da)
AU (1)	AU609718B2 (da)
CA (1)	CA1288048C (da)
DE (1)	DE3771389D1 (da)
DK (1)	DK175238B1 (da)
ES (1)	ES2031467T3 (da)
FI (1)	FI88459C (da)
GR (1)	GR3002317T3 (da)
HK (1)	HK39094A (da)
IE (1)	IE60259B1 (da)
IL (1)	IL82615A (da)
IT (1)	IT1205667B (da)
NO (1)	NO173365C (da)
NZ (1)	NZ220394A (da)
ZA (1)	ZA873663B (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4983595A (en) *	1986-05-22	1991-01-08	Syntex (U.S.A.) Inc.	Aqueous steroid formulations for nasal administration
JPH0311016A (ja) *	1989-06-09	1991-01-18	Tokyo Tanabe Co Ltd	ピリド［１，２―ａ］ピリミジン誘導体の水性製剤
GB9103824D0 (en) *	1991-02-23	1991-04-10	Fisons Ag	Formulation
US5338732A (en) *	1991-06-18	1994-08-16	Bristol-Myers Squibb Company	Megestrol acetate formulation
WO1995011042A1 (fr) *	1993-10-21	1995-04-27	Hisamitsu Pharmaceutical Co., Inc.	Composition administree par voie nasale et preparation contenant celle-ci
US5762917A (en) *	1994-09-27	1998-06-09	Virotex Corporation	Method and composition for cleansing wounds with minimal cytotoxicity for minimal scarring
US5976573A (en) *	1996-07-03	1999-11-02	Rorer Pharmaceutical Products Inc.	Aqueous-based pharmaceutical composition
US8466134B1 (en)	1998-06-26	2013-06-18	Athena Neurosciences, Inc.	Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
US6241969B1 (en)	1998-06-26	2001-06-05	Elan Corporation Plc	Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
GB9918559D0 (en) *	1999-08-07	1999-10-06	Glaxo Wellcome Kk	Novel pharmaceutical formulation
US6610271B2 (en) *	2000-05-10	2003-08-26	University Of Kentucky Research Foundation	System and method for intranasal administration of lorazepam
US20060083691A1 (en) *	2000-05-10	2006-04-20	Wermeling Daniel P	Intranasal opioid compositions, delivery devices and methods of using same
US20040115133A1 (en) *	2000-05-10	2004-06-17	Wermeling Daniel P.	Intranasal opioid compositions
US6948492B2 (en)	2000-08-15	2005-09-27	University Of Kentucky Research Foundation	Programmable multi-dose intranasal drug delivery device
US20040176359A1 (en) *	2001-02-20	2004-09-09	University Of Kentucky Research Foundation	Intranasal Benzodiazepine compositions
GB2389530B (en)	2002-06-14	2007-01-10	Cipla Ltd	Pharmaceutical compositions
WO2004012662A2 (en)	2002-08-01	2004-02-12	Aesgen, Inc.	Improved treatment of cancer with glutamine
US7148211B2 (en) *	2002-09-18	2006-12-12	Genzyme Corporation	Formulation for lipophilic agents
US7404489B1 (en)	2003-03-04	2008-07-29	Qol Medical, Llc	Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
JP4632687B2 (ja) *	2003-04-25	2011-02-16	ロート製薬株式会社	点鼻剤
JP5238779B2 (ja) *	2003-04-25	2013-07-17	ロート製薬株式会社	点鼻剤
CA2550811C (en) *	2003-12-24	2012-05-01	Jane Hirsh	Temperature-stable formulations, and methods of development thereof
GB0400804D0 (en)	2004-01-14	2004-02-18	Innoscience Technology Bv	Pharmaceutical compositions
US20060045850A1 (en) *	2004-08-30	2006-03-02	Qpharma, Llc	Nasal delivery of cyclodextrin complexes of anti-inflammatory steroids
KR20070104884A (ko)	2004-11-24	2007-10-29	메드포인트 헬쓰케어 인크.	아젤라스틴을 포함하는 조성물 및 이의 사용 방법
WO2007022345A2 (en)	2005-08-17	2007-02-22	Fleming And Company, Pharmaceuticals	Vitamin b12 nasal spray and method of use
KR100767976B1 (ko)	2006-08-25	2007-10-18	한국유나이티드제약 주식회사	비내 건조증에 효과적인 약제학적 조성물
CN106389330A (zh)	2007-01-19	2017-02-15	哈南亚有限公司	用于递送治疗剂的方法和组合物
US20080275030A1 (en)	2007-01-19	2008-11-06	Sveinbjorn Gizurarson	Methods and Compositions for the Delivery of a Therapeutic Agent
JP2011001317A (ja) *	2009-06-19	2011-01-06	Fumakilla Ltd	鼻用洗浄剤
CN105188758A (zh) *	2013-03-15	2015-12-23	梅迪奇斯医药公司	氟尼缩松的局部组合物及治疗方法
US11135155B2 (en)	2014-07-08	2021-10-05	Hikma Pharmaceuticals Usa Inc.	Liquid naloxone spray
JP6097787B2 (ja) *	2015-06-09	2017-03-15	パルファーマシューティカル，インコーポレーテッド	鼻内送達用シアノコバラミン低粘度水性製剤
US11510859B2 (en)	2015-07-16	2022-11-29	Marinomed Biotech Ag	Method for improving aqueous solubility of water-insoluble or slightly water-soluble drugs
MY196065A (en)	2015-07-16	2023-03-13	Marinomed Biotech Ag	Method for improving aqueous solubility of water-insoluble or slightly water-soluble drugs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2989437A (en) *	1955-06-08	1961-06-20	Upjohn Co	Anti-inflammatory and anti-bacterial decongestant nasal spray compositions
MX3864E (es) *	1975-05-27	1981-08-26	Syntex Corp	Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
DE2750090A1 (de) *	1976-11-19	1978-06-01	Sandoz Ag	Neue verabreichungsformen fuer organische verbindungen
US4444762A (en) *	1980-04-04	1984-04-24	Nelson Research & Development Company	Vehicle composition containing 1-substituted azacyclopentan-2-ones
US4344940A (en) *	1981-11-30	1982-08-17	E. R. Squibb & Sons, Inc.	Steroid formulation containing dipotassium EDTA
US4603131A (en) *	1982-04-26	1986-07-29	Bernstein Joel E	Method and composition for treating and preventing irritation of the mucous membranes of the nose

1986
- 1986-05-22 US US06/866,171 patent/US4782047A/en not_active Expired - Lifetime
1987
- 1987-05-21 NO NO872127A patent/NO173365C/no unknown
- 1987-05-21 IL IL82615A patent/IL82615A/xx not_active IP Right Cessation
- 1987-05-21 NZ NZ220394A patent/NZ220394A/en unknown
- 1987-05-21 CA CA000537690A patent/CA1288048C/en not_active Expired - Lifetime
- 1987-05-21 IE IE133587A patent/IE60259B1/en not_active IP Right Cessation
- 1987-05-21 IT IT20621/87A patent/IT1205667B/it active
- 1987-05-21 DK DK198702586A patent/DK175238B1/da active
- 1987-05-21 ZA ZA873663A patent/ZA873663B/xx unknown
- 1987-05-21 DE DE8787107416T patent/DE3771389D1/de not_active Expired - Lifetime
- 1987-05-21 ES ES198787107416T patent/ES2031467T3/es not_active Expired - Lifetime
- 1987-05-21 EP EP87107416A patent/EP0246652B1/en not_active Expired - Lifetime
- 1987-05-21 AU AU73273/87A patent/AU609718B2/en not_active Ceased
- 1987-05-21 AT AT87107416T patent/ATE65183T1/de not_active IP Right Cessation
- 1987-05-21 JP JP62126846A patent/JP2521291B2/ja not_active Expired - Lifetime
- 1987-05-21 KR KR1019870005032A patent/KR950008308B1/ko not_active IP Right Cessation
- 1987-05-21 FI FI872231A patent/FI88459C/fi not_active IP Right Cessation
1991
- 1991-07-18 GR GR91400394T patent/GR3002317T3/el unknown
1994
- 1994-04-21 HK HK39094A patent/HK39094A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
NZ220394A (en)	1990-04-26
FI88459C (fi)	1993-05-25
IT8720621A0 (it)	1987-05-21
ATE65183T1 (de)	1991-08-15
IT1205667B (it)	1989-03-31
IL82615A0 (en)	1987-11-30
KR950008308B1 (ko)	1995-07-27
EP0246652A3 (en)	1988-02-03
FI872231A0 (fi)	1987-05-21
ES2031467T3 (es)	1992-12-16
CA1288048C (en)	1991-08-27
IE60259B1 (en)	1994-06-29
AU7327387A (en)	1987-11-26
EP0246652B1 (en)	1991-07-17
NO872127L (no)	1987-11-23
US4782047A (en)	1988-11-01
AU609718B2 (en)	1991-05-09
NO173365C (no)	1993-12-08
JP2521291B2 (ja)	1996-08-07
ZA873663B (en)	1988-12-28
KR870010862A (ko)	1987-12-18
NO872127D0 (no)	1987-05-21
HK39094A (en)	1994-04-29
DK258687A (da)	1987-11-23
GR3002317T3 (en)	1992-12-30
DE3771389D1 (de)	1991-08-22
NO173365B (no)	1993-08-30
IE871335L (en)	1987-11-22
IL82615A (en)	1991-11-21
EP0246652A2 (en)	1987-11-25
JPS62283927A (ja)	1987-12-09
DK175238B1 (da)	2004-07-19
FI88459B (fi)	1993-02-15
FI872231L (fi)	1987-11-23

Publication	Publication Date	Title
DK258687A (da)	1987-11-23	Intranaslat praeparat
LV10907A (lv)	1995-12-20	Interferona polietilenglikola atvasinajums
RU93047799A (ru)	1996-03-20	Композиции, содержащие ретиноевые кислоты и токоферол
DE3381396D1 (de)	1990-05-10	Formulierung nicht irritierender ophthalmischer waesseriger zusammensetzungen fuer okular-therapeutische mittel.
DK581989A (da)	1989-11-20	Steroidlotion
DE3766200D1 (de)	1990-12-20	L-dopa enthaltendes arzneimittel.
DE3870064D1 (de)	1992-05-21	Waessrige loesungen von doxorubicinhydrochlorid.
WO1991015200A3 (en)	1992-03-05	Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
PH27567A (en)	1993-08-18	Topical compositions
IL76393A (en)	1988-06-30	Stable parenteral aqueous pharmaceutical compositions of dezocine
ATE23161T1 (de)	1986-11-15	3-deazaguanin-sulfonsaeuresalze.
IT1262960B (it)	1996-07-23	Composizioni farmaceutiche somministrabili per via intranasale contenenti calcitonina quale principio attivo.
AU1257888A (en)	1989-01-12	Stable, injectable solutions of vinca dimer salts
DE68905577D1 (de)	1993-04-29	Doxorubicin-loesungen.